Phibro Animal Health Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Phibro Animal Health wird ein jährliches Gewinn- und Umsatzwachstum von 37.7% bzw. 2.9% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 48.3% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 18.8% betragen.

Wichtige Informationen

51.5%

Wachstumsrate der Gewinne

72.6%

EPS-Wachstumsrate

Pharmaceuticals Gewinnwachstum	23.9%
Wachstumsrate der Einnahmen	4.2%
Zukünftige Eigenkapitalrendite	20.5%
Analystenabdeckung	Low
Zuletzt aktualisiert	10 Sep 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Phibro Animal Health Corporation's (NASDAQ:PAHC) Shares Bounce 26% But Its Business Still Trails The Industry

Sep 14

Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12

Aug 29

Phibro Animal Health (NASDAQ:PAHC) Will Pay A Dividend Of $0.12

Aug 15

New Forecasts: Here's What Analysts Think The Future Holds For Phibro Animal Health Corporation (NASDAQ:PAHC)

May 14

Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12

May 11

Phibro Animal Health: An Interesting Deal With Zoetis For A Struggling Business

May 01

Market Participants Recognise Phibro Animal Health Corporation's (NASDAQ:PAHC) Earnings Pushing Shares 30% Higher

Apr 30

Is Phibro Animal Health Corporation (NASDAQ:PAHC) Worth US$13.8 Based On Its Intrinsic Value?

Dec 23

Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12

Aug 26

Phibro Animal Non-GAAP EPS of $0.36 misses by $0.02, revenue of $255.3M beats by $5.26M

Aug 24

Is Phibro Animal Health (NASDAQ:PAHC) A Risky Investment?

Aug 24

Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12

Jul 29

Phibro Animal declares $0.12 dividend

Jul 25

Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be US$0.12

May 06

Phibro Animal Health (NASDAQ:PAHC) Has Announced A Dividend Of US$0.12

Feb 11

Gewinn- und Umsatzwachstumsprognosen

NasdaqGM:PAHC - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
6/30/2027	1,319	46	53	53	2
6/30/2026	1,224	35	56	72	3
6/30/2025	1,042	30	39	64	3
6/30/2024	1,018	2	46	88	N/A
3/31/2024	1,000	13	40	79	N/A
12/31/2023	982	15	37	74	N/A
9/30/2023	977	21	4	40	N/A
6/30/2023	978	33	-38	13	N/A
3/31/2023	978	29	-58	-5	N/A
12/31/2022	972	36	-60	-5	N/A
9/30/2022	960	46	-36	17	N/A
6/30/2022	942	49	-5	32	N/A
3/31/2022	907	59	1	33	N/A
12/31/2021	879	53	14	44	N/A
9/30/2021	853	49	21	50	N/A
6/30/2021	833	54	19	48	N/A
3/31/2021	799	43	17	49	N/A
12/31/2020	798	44	27	59	N/A
9/30/2020	806	43	31	65	N/A
6/30/2020	800	34	25	59	N/A
3/31/2020	818	37	36	70	N/A
12/31/2019	813	38	25	59	N/A
9/30/2019	818	41	11	42	N/A
6/30/2019	828	55	17	47	N/A
3/31/2019	836	68	17	42	N/A
12/31/2018	839	73	28	50	N/A
9/30/2018	827	65	47	66	N/A
6/30/2018	820	65	51	70	N/A
3/31/2018	803	58	N/A	73	N/A
12/31/2017	784	62	N/A	88	N/A
9/30/2017	770	68	N/A	82	N/A
6/30/2017	764	65	N/A	98	N/A
3/31/2017	759	64	N/A	111	N/A
12/31/2016	752	59	N/A	79	N/A
9/30/2016	752	76	N/A	61	N/A
6/30/2016	752	83	N/A	37	N/A
3/31/2016	747	78	N/A	32	N/A
12/31/2015	751	76	N/A	49	N/A
9/30/2015	748	60	N/A	49	N/A
6/30/2015	749	60	N/A	69	N/A
3/31/2015	747	32	N/A	30	N/A
12/31/2014	733	22	N/A	9	N/A
9/30/2014	717	10	N/A	17	N/A
6/30/2014	692	-3	N/A	-1	N/A
3/31/2014	672	20	N/A	27	N/A
12/31/2013	662	18	N/A	20	N/A
9/30/2013	652	23	N/A	2	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: PAHCDas prognostizierte Gewinnwachstum (37.7% pro Jahr) liegt über der Sparquote (2.5%).

Ertrag vs. Markt: PAHCDie Erträge des Unternehmens (37.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (15.2% pro Jahr).

Hohe Wachstumserträge: PAHCEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: PAHCDie Einnahmen des Unternehmens (2.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.8% pro Jahr).

Hohe Wachstumseinnahmen: PAHCDie Einnahmen des Unternehmens (2.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: PAHCDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (20.5%)

Phibro Animal Health Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Phibro Animal Health Corporation Provides Earning Guidance for the Year Ending June 30, 2025

Consensus EPS estimates fall by 11%

Price target increased by 12% to US$12.00

Phibro Animal Health Corporation Updates Earnings Guidance for the Year 2024

Consensus EPS estimates fall by 43%

Phibro Animal Health Corporation Reaffirms Earnings Guidance for the Fiscal Year 2024

Recent updates

Phibro Animal Health Corporation's (NASDAQ:PAHC) Shares Bounce 26% But Its Business Still Trails The Industry

Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12

Phibro Animal Health Corporation Provides Earning Guidance for the Year Ending June 30, 2025

Phibro Animal Health (NASDAQ:PAHC) Will Pay A Dividend Of $0.12

Phibro Animal Health Corporation to Report Q4, 2024 Results on Aug 28, 2024

Phibro Animal Health Corporation Declares Quarterly Dividend, Payable on September 25, 2024

Chairman notifies of intention to sell stock

Consensus EPS estimates fall by 11%

New Forecasts: Here's What Analysts Think The Future Holds For Phibro Animal Health Corporation (NASDAQ:PAHC)

Price target increased by 12% to US$12.00

Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12

Phibro Animal Health Corporation Updates Earnings Guidance for the Year 2024

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Phibro Animal Health Corporation Declares Quarterly Dividend, Payable on June 26, 2024

Phibro Animal Health: An Interesting Deal With Zoetis For A Struggling Business

Market Participants Recognise Phibro Animal Health Corporation's (NASDAQ:PAHC) Earnings Pushing Shares 30% Higher

Phibro Animal Health Corporation (NasdaqGM:PAHC) entered into a definitive agreement to acquire Medicated feed additive product portfolio, certain water soluble products and related assets of Zoetis Inc. (NYSE:ZTS) for approximately $350 million.

Investor sentiment improves as stock rises 29%

Phibro Animal Health Corporation to Report Q3, 2024 Results on May 08, 2024

Chairman notifies of intention to sell stock

Upcoming dividend of US$0.12 per share

Consensus EPS estimates fall by 43%

Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12

Second quarter dividend of US$0.12 announced

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Phibro Animal Health Corporation Reaffirms Earnings Guidance for the Fiscal Year 2024

Phibro Animal Health Corporation Declares Quarterly Cash Dividend, Payable on March 27, 2024

Phibro Animal Health Corporation Announces Chief Financial Officer Changes, Effective February 9, 2024

Price target decreased by 10% to US$11.20

Phibro Animal Health Corporation to Report Q2, 2024 Results on Feb 07, 2024

Phibro Animal Health (NASDAQ:PAHC) Use Of Debt Could Be Considered Risky

Investor sentiment improves as stock rises 18%

Now 20% undervalued after recent price drop

Upcoming dividend of US$0.12 per share at 4.6% yield

Investor sentiment deteriorates as stock falls 16%

Price target decreased by 25% to US$12.50

Phibro Animal Health Corporation Provides Consolidated Earnings Guidance for the Year Ending June 30, 2024

Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Phibro Animal Health Corporation Declares Quarterly Cash Dividend, Payable on December 20, 2023

A Look At The Fair Value Of Phibro Animal Health Corporation (NASDAQ:PAHC)

Phibro Animal Health Corporation to Report Q1, 2024 Results on Nov 08, 2023

Phibro Animal Health Corporation, Annual General Meeting, Nov 06, 2023

Phibro Animal Health Corporation Announces Chief Financial Officer Changes

Consensus EPS estimates fall by 28%, revenue upgraded

Phibro Animal Health Corporation Provides Consolidated Earnings Guidance for the Year Ending June 30, 2024

Full year 2023 earnings: EPS misses analyst expectations

Upcoming dividend of US$0.12 per share at 3.2% yield

Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12

Phibro Animal Health Corporation to Report Q4, 2023 Results on Aug 30, 2023

Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12

Phibro Animal Health Corporation Declares Quarterly Cash Dividend, Payable on September 27, 2023

Upcoming dividend of US$0.12 per share at 3.6% yield

Third quarter 2023 earnings: EPS misses analyst expectations

Phibro Animal Health Corporation Reiterates Earnings Guidance for the Year Ending June 30, 2023

Chairman notifies of intention to sell stock

Upcoming dividend of US$0.12 per share at 2.9% yield

Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Phibro Animal Health Corporation Revises Earnings Guidance for the Fiscal Year Ending June 30, 2023

Phibro Animal Health Corporation Appoints Alejandro Bernal to Its Board of Directors

Phibro Animal Health Corporation to Report Q2, 2023 Results on Feb 08, 2023

Is Phibro Animal Health Corporation (NASDAQ:PAHC) Worth US$13.8 Based On Its Intrinsic Value?

Chairman notifies of intention to sell stock

Upcoming dividend of US$0.12 per share

Consensus forecasts updated

Insufficient new directors

First quarter 2023 earnings: EPS misses analyst expectations

Phibro Animal Health Corporation Revises Earnings Guidance for the Fiscal Year Ending June 30, 2023